Characteristics of Speakers at US FDA Advisory Committee Meetings on Drug Approval
This cross-sectional study assesses whether the characteristics of people who spoke at US Food and Drug Administration Human Drug Advisory Committee meetings on new drug approvals were associated with recommendations for drug approval.
Authors
- Leah Z. Rand (ORCID: https://orcid.org/0000-0003-3262-1584)
- Helen Mooney
- Dongzhe Hong (ORCID: https://orcid.org/0000-0002-6400-9667)
- David C. Klein (ORCID: https://orcid.org/0000-0002-1792-5806)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Benjamin N. Rome (ORCID: https://orcid.org/0000-0001-5776-3293)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1001/jamainternmed.2025.6107
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00